NASDAQ: AMGN
Amgen Inc Stock Ownership - Who owns Amgen?

Insider buying vs selling

Have Amgen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Murdo GordonEVP Global Commercial Ops2025-03-174,039$313.71
$1.27MSell
Derek MillerSVP Human Resources2025-03-17930$313.71
$291.75kSell
Peter H. GriffithEVP CFO2025-03-173,305$313.71
$1.04MSell
Jonathan P. GrahamEVP Gen. Counsel Secy.2025-03-173,150$313.71
$988.19kSell
Robert A. BradwayChairman CEO and President2025-03-1712,853$313.71
$4.03MSell
David M. ReeseEVP Chief Technology Officer2025-03-173,635$313.71
$1.14MSell
Matthew C. BuschVP Finance CAO2025-03-17174$313.71
$54.59kSell
Rachna KhoslaSVP Business Development2025-03-17489$313.71
$153.40kSell
Esteban SantosEVP Operations2025-03-173,393$313.71
$1.06MSell
Nancy A. GrygielSVP CCO2025-03-17524$313.71
$164.38kSell

1 of 5

AMGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMGN insiders and whales buy or sell their stock.

AMGN Shareholders

What type of owners hold Amgen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc9.81%52,721,795$14.93BInstitution
Blackrock Inc8.50%45,646,148$12.92BInstitution
State Street Corp5.48%29,434,414$8.33BInstitution
Morgan Stanley2.71%14,559,622$4.12BInstitution
Charles Schwab Investment Management Inc2.46%13,205,604$3.74BInstitution
Primecap Management Co2.42%13,002,125$3.68BInstitution
Geode Capital Management LLC2.32%12,475,032$3.53BInstitution
Capital International Investors2.27%12,212,065$3.46BInstitution
Wells Fargo Company1.33%7,134,605$2.02BInstitution
Capital World Investors1.21%6,495,710$1.84BInstitution

1 of 3

AMGN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMGN77.54%1.02%Net SellingNet Selling
SNY20.91%0.00%
PFE65.81%0.27%Net BuyingNet Buying
GILD85.10%1.11%Net SellingNet Selling
BMY78.09%0.37%Net SellingNet Selling

Amgen Stock Ownership FAQ

Who owns Amgen?

Amgen (NASDAQ: AMGN) is owned by 77.54% institutional shareholders, 1.02% Amgen insiders, and 21.44% retail investors. Vanguard Group Inc is the largest individual Amgen shareholder, owning 52.72M shares representing 9.81% of the company. Vanguard Group Inc's Amgen shares are currently valued at $15.21B.

If you're new to stock investing, here's how to buy Amgen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.